A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IMT / idiopathic macular telangiectasia

[Related PubMed/MEDLINE]
Total Number of Papers: 28
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IMT  (>> Co-occurring Abbreviation)
Long Form:   idiopathic macular telangiectasia
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS. ---
2018 Long-Term Follow-Up of an Atypical Case of Idiopathic Macular Telangiectasia. VEGF
2017 Unusual Presentation of Type 1 Idiopathic Macular Telangiectasia. anti-VEGF, FA, SD-OCT
2016 Dexamethasone Implant for the Treatment of Type 1 Idiopathic Macular Telangiectasia. BCVA, CMT, MV
2016 Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia. BCVA, CMT, OCT
2015 Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children. CME, CRT, DEX, IOP, VA
2015 Idiopathic Macular Telangiectasia Type 1 with Ruptured Retinal Arterial Macroaneurysm Post Intravitreal Bevacizumab. RAM
2014 Crystalline deposits in the macula - tamoxifen maculopathy or macular telangiectasia? FAF, FFA, SD-OCT
2014 Macular oedema in idiopathic macular telangiectasia type 1 responsive to aflibercept but not bevacizumab. ---
10  2014 Type 1 idiopathic macular telangiectasia associated with type 3 neovascularization. anti-VEGF, BCVA, LE, SD-OCT
11  2013 Different treatment modalities for choroidal neovascularization in two eyes of one patient with bilateral type 2A parafoveal telangiectasia. BCVA, LE, PDT, RE
12  2013 Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia. FA, IVB, OCT, VA
13  2013 Unusual presentations of type 2 idiopathic macular telangiectasia. FA, ICGA, SD-OCT
14  2013 [Idiopathic macular telangiectasia: clinical appearance, imaging and treatment]. SD-OCT
15  2011 The continuum of primary retinal telangiectasia. ---
16  2010 Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia. FA
17  2010 Intravitreal bevacizumab therapy for idiopathic macular telangiectasia. OCT
18  2010 Type II idiopathic macular telangiectasia and soft confluent drusen. FA, ICGA
19  2010 Unilateral Idiopathic Macular Telangiectasia with Choroidal Neovascularization. FA, OCT, RCA
20  2010 [Idiopathic macular telangiectasia - follow-up with and without laser photocoagulation]. ---
21  2009 Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. FAF
22  2008 Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. MPOD
23  2008 Bevacizumab in the treatment of idiopathic macular telangiectasia. BCVA, FA, OCT
24  2008 Characterization of idiopathic macular telangiectasia type 2 by fundus fluorescein angiography in Indian population. FAZ, FFA, SRN
25  2008 Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia. GLD, PDT, SRNVM
26  2008 Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. OCT
27  2007 Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. ETDRS, OCT, VA
28  2007 Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. LIS